Catabasis Pharmaceuticals to Present at the Upcoming 2020 Solebury Trout Virtual Investor Conference
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, plans to present a corporate overview and provide a business update at the upcoming Solebury Trout Virtual Investor Conference on Tuesday, March 31, 2020 at 12:30pm EDT.
A webcast of the presentation will be available in the investors section of the Company's website www.catabasis.com, and will be archived for 30 days following the presentation.
About Catabasis
At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients and their families. Our lead program is edasalonexent, an NF-kB inhibitor in Phase 3 development for the treatment of Duchenne muscular dystrophy. For more information on edasalonexent and our Phase 3 PolarisDMD trial, please visit www.catabasis.com.
The Prelude Network® (Prelude), the largest provider of comprehensive fertility services and clinics across North America, announces today nine of its clinics have been named an America's Best Fertility Clinic in 2024....
The Eleanor Crook Foundation (ECF) and CRI Foundation have made a $1.5 million investment with Action Against Hunger to accelerate local adaptation and country-led uptake of the new global malnutrition guidelines from the World Health Organization...
In honor of Wounded Heroes Day in Charlotte, NC, Gary Sinise & The Lt. Dan Band will perform a free concert on Sunday, April 21st, at 7 p.m. at the Revelry North End. Hosted by The Independence Fund, the concert celebrates the 4th annual Wounded...
EARTHDAY.ORG, the global force behind Earth Day, is partnering with the Out of Home Advertising Association of America (OAAA), the leading trade group representing the entire out of home (OOH) advertising industry, for the sixth year in a row! OAAA...
Therapist Cara Behan LMFT, launches Yoga & Meditation Membership in effort to address growing mental health crisis and need for accessible care in communities across California. A Licensed Marriage and Family Therapist, certified yoga teacher, and...
A new study by surgeon-scientists at Hospital for Special Surgery (HSS) found that 25% of patients with hip impingement who underwent modern arthroscopy for their condition experienced a delay in the natural progression of osteoarthritis. The...
